Table 1.
Differences between influencing factors of AKI and non-AKI groups
| Influencing factors | AKI, n=288 | Non-AKI, n=794 | Total, n=1082 |
|---|---|---|---|
| Preoperative factors | |||
| Age | 57 (49, 66) | 51 (43, 62) | 54 (45, 63) |
| Sex | |||
| Male | 202 (70.1%) | 388 (48.9%) | 590 (54.5%) |
| Female | 86 (29.9%) | 406 (51.1%) | 492 (45.5%) |
| Diabetes | |||
| Yes | 20 (6.9%) | 32 (4.0%) | 52 (4.8%) |
| No | 268 (93.1%) | 762 (96.0%) | 1030 (95.2%) |
| Hypertension | |||
| Yes | 99 (34.4%) | 130 (16.4%) | 229 (21.2%) |
| No | 189 (65.6%) | 664 (83.6%) | 853 (78.8%) |
| Anemia | |||
| Yes | 93 (32.3%) | 205 (25.8%) | 298 (27.5%) |
| No | 195 (67.7%) | 589 (74.2%) | 784 (72.5%) |
| Intraoperative factors | |||
| CPB time | 186 (122, 230) | 161 (105, 203) | 168 (110, 208) |
| RBC | 5.5 (1.5, 7) | 3.6 (0, 5.5) | 4.1 (0, 6) |
| Plasma | 460 (0, 600) | 321 (0, 600) | 358 (0, 600) |
| Cryoprecipitate | 4 (0, 0) | 2.3 (0, 0) | 2.7 (0, 0) |
| Albumin | 100 (20, 100) | 95 (20, 100) | 96 (20, 100) |
| Voluven® | 376 (0, 500) | 391 (0, 500) | 387 (0, 500) |
| Gelofusine® | 354 (0, 768) | 232 (0, 500) | 264 (0, 500) |
| Equilibrium liquid | 2156 (1425, 2500) | 2095 (1500, 2500) | 2111 (1500, 2500) |
| 5% SBS | 70 (0, 90) | 32 (0, 0) | 42 (0, 0) |
| Furosemide | 8 (0, 20) | 7 (0, 15) | 7 (0, 15) |
| Intraoperative blood loss | 894 (300, 800) | 565 (300, 600) | 653 (300, 600) |
| Urine | 1436 (600, 2000) | 1485 (800, 2000) | 1472 (800, 2000) |